Navigation Links
UCI-led study uncovers how Salmonella avoids the body's immune response
Date:3/14/2012

Irvine, Calif., March 14, 2012 UC Irvine researchers have discovered how Salmonella, a bacterium found in contaminated raw foods that causes major gastrointestinal distress in humans, thrives in the digestive tract despite the immune system's best efforts to destroy it.

Their findings help explain why Salmonella is difficult to eradicate and point to new approaches for possible treatments. Most people infected with Salmonella suffer from diarrhea, fever and abdominal cramps for up to seven days before the infection resolves.

Lead researcher Manuela Raffatellu, a UCI assistant professor of microbiology & molecular genetics, and colleagues identified a novel molecular mechanism that allows Salmonella to survive. Results of their study appear in the March issue of Cell Host & Microbe.

Pathogens like Salmonella flourish and cause disease in humans through a process by which they acquire metal ions, such as zinc, from the body. One of the body's key immune responses is to flood the infected area with antimicrobial proteins that include calprotectin, which removes zinc. Without enough of this vital element, most pathogens eventually die.

Raffatellu's team found, however, that salmonellae overcome this immune response by expressing specialized transporter proteins that enable the bacteria to acquire zinc in spite of calprotectin reducing the amount available in the digestive tract. This distinctive mechanism lets salmonellae continue proliferating.

At the same time, calprotectin inadvertently promotes Salmonella growth by killing the microbes that normally reside within the intestines and help the immune system battle pathogenic bacteria.

"We're beginning to learn more about the mechanisms that allow pathogens like Salmonella to evade our natural defenses and make us sick," Raffatellu said. "In light of this, if we can devise therapies that block the acquisition of zinc and other metals by Salmonella specifically, we can fight this infection."

Additionally, she said, the new findings may have relevance for other illnesses, such as inflammatory bowel disease and colon cancer, in which high levels of calprotectin are detected.


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Related biology news :

1. Gases drawn into smog particles stay there, UCI-led study reveals
2. UCI-led team finds new way to boost potency of marijuana-like chemical in body
3. UCI-led butterfly study sheds light on convergent evolution
4. Study demonstrates cells can acquire new functions through transcriptional regulatory network
5. University of Houston study shows BP oil spill hurt marshes, but recovery possible
6. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
7. Crystal structure of archael chromatin clarified in new study
8. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
9. 15-year study: When it comes to creating wetlands, Mother Nature is in charge
10. BYU study: Using a gun in bear encounters doesnt make you safer
11. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2016)... Securus Technologies, a leading provider of civil and criminal ... monitoring, announced today that it has offered a challenge ... technology judge determine who has the largest and best ... platform, and the best customer service. "ICSolutions ... we do – which clearly is not the case ...
(Date:11/16/2016)... 2016 Sensory Inc ., a ... for consumer electronics, and VeriTran , a ... industry, today announced a global partnership that will ... authenticate users of mobile banking and mobile payments ... software which requires no specialized biometric scanners, yet ...
(Date:11/14/2016)... 2016  xG Technology, Inc. ("xG" or the "Company") ... communications for use in challenging operating environments, announced its ... Management will hold a conference call to discuss these ... Time (details below). Key Recent Accomplishments ... binding agreement to acquire Vislink Communication Systems. The purchase ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... Diego (PRWEB) , ... December 07, 2016 , ... ... data from its phase I/II dose escalation and expansion clinical trial for its ... in Vienna, Austria. The purpose of the trial was to determine the safety, ...
(Date:12/7/2016)... , Dec. 7, 2016 Neogen Corporation ... named Dr. Dan Kephart as its chief ... Kephart will assume his responsibilities at Neogen effective Jan. ... development director for the agribusiness unit of Thermo Fisher ... development at Life Technologies. His extensive industry experience also ...
(Date:12/7/2016)... 2016  Nordion, a standalone business of Sterigenics ... today,s award by the United States Department of ... the Phase II cooperative agreement funding to GA ... University of Missouri Research Reactor Center (MURR ® ... establishment of a new, reliable supply of molybdenum ...
(Date:12/7/2016)... 7, 2016  Vyriad Inc. announced today the appointment ... Board of Directors. "We are delighted to ... business and develop our oncolytic viruses as the next ... Stephen Russell , MD, PhD, CEO of Vyriad. "Al ... vision and passion for making a difference for cancer ...
Breaking Biology Technology: